These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8914233)

  • 1. Long-term cyclosporin A pharmacokinetic profiles in pediatric renal transplant recipients.
    Kelles A; Van Damme-Lombaerts R; Tjandra-Maga TB; Van Damme B
    Transpl Int; 1996; 9(6):546-50. PubMed ID: 8914233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of pharmacokinetics of cyclosporine A in cadaveric and living-related renal transplant recipients and in an experimental rat model of renal failure.
    Sugioka N; Fujimoto K; Tanaka Y; Fukushima K; Ito Y; Kokuhu T; Okamoto M; Yoshimura N; Takada K
    Drug Metab Lett; 2009 Aug; 3(3):152-61. PubMed ID: 19702545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
    Canadian Neoral Renal Transplantation Study Group
    Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of therapeutic monitoring of cyclosporine through C2 and AUC(0-4) during the first 24 months following kidney transplantation].
    Vavić N; Ignjatović L; Drasković B; Hrvacević R; Kovacević Z; Paunić Z
    Vojnosanit Pregl; 2008 Feb; 65(2):119-27. PubMed ID: 18365668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Neoral and Sandimmun cyclosporin A pharmacokinetic profiles in young renal transplant recipients.
    Kabasakul SC; Clarke M; Kane H; Karsten J; Clark G
    Pediatr Nephrol; 1997 Jun; 11(3):318-21. PubMed ID: 9203180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin A absorption profiles in pediatric renal transplant recipients predict the risk of acute rejection.
    Weber LT; Armstrong VW; Shipkova M; Feneberg R; Wiesel M; Mehls O; Zimmerhackl LB; Oellerich M; Tönshoff B;
    Ther Drug Monit; 2004 Aug; 26(4):415-24. PubMed ID: 15257072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic monitoring of pediatric renal transplant patients with conversion to generic cyclosporin.
    Riva N; Guido PC; Ibañez J; Licciardone N; Rousseau M; Mato G; Monteverde M; Schaiquevich P
    Int J Clin Pharm; 2014 Aug; 36(4):779-86. PubMed ID: 24861769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function after pediatric cardiac transplantation: the effect of early cyclosporin dosage.
    Hornung TS; de Goede CG; O'Brien C; Moghal NE; Dark JH; O'Sullivan Fp
    Pediatrics; 2001 Jun; 107(6):1346-50. PubMed ID: 11389255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of cyclosporine C2 monitoring in pediatric heart transplant recipients.
    Hmiel SP; Canter C; Shepherd R; Lassa-Claxton S; Nadler M
    Pediatr Transplant; 2007 Aug; 11(5):524-9. PubMed ID: 17631021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A (Neoral) in pediatric organ transplantation. Neoral Pediatric Study Group.
    Hoyer PF
    Pediatr Transplant; 1998 Feb; 2(1):35-9. PubMed ID: 10084758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.
    Schädeli F; Marti HP; Frey FJ; Uehlinger DE
    Clin Pharmacokinet; 2002; 41(1):59-69. PubMed ID: 11825097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cyclosporine in pediatric long-term liver transplant recipients converted from Sandimmun to Neoral.
    Melter M; Rodeck B; Kardorff R; Hoyer PF; Brodehl J
    Transpl Int; 1997; 10(6):419-25. PubMed ID: 9428114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of Neoral in pediatric recipients of primary liver transplants.
    Wallemacq PE; Reding R; Sokal EM; de Ville de Goyet J; Clement de Clety S; Van Leeuw V; De Backer M; Otte JB
    Transpl Int; 1997; 10(6):466-70. PubMed ID: 9428122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of appropriate blood level in continuous intravenous infusion from trough concentrations after oral administration based on area under trough level in tacrolimus and cyclosporine therapy.
    Nakamura Y; Takeuchi H; Okuyama K; Akashi T; Jojima Y; Konno O; Akashi I; Hama K; Iwahori T; Ashizawa T; Hirano T; Oka K; Matsuno N; Nagao T
    Transplant Proc; 2005 May; 37(4):1725-7. PubMed ID: 15919445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketoconazole alters cyclosporine pharmacokinetic profile and may predispose to acute rejection.
    Dominguez J; Kompatzki A; Foradori A; Norambuena R
    Transplant Proc; 2003 Nov; 35(7):2522-3. PubMed ID: 14612002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs.
    Lytton SD; Berg U; Nemeth A; Ingelman-Sundberg M
    Clin Exp Immunol; 2002 Feb; 127(2):293-302. PubMed ID: 11876753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin twice or three times daily dosing in pediatric transplant patients - it is not the same!
    Filler G; de Barros VR; Jagger JE; Christians U
    Pediatr Transplant; 2006 Dec; 10(8):953-6. PubMed ID: 17096765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacokinetic comparison of the corn oil versus microemulsion gelcap formulation of cyclosporin used de novo after renal transplantation.
    Amante AJ; Meier-Kriesche HU; Schoenberg L; Kahan BD
    Transpl Int; 1997; 10(3):217-22. PubMed ID: 9163863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of mycophenolate mofetil are influenced by concomitant immunosuppression.
    Filler G; Zimmering M; Mai I
    Pediatr Nephrol; 2000 Feb; 14(2):100-4. PubMed ID: 10684356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of different pharmacokinetics including relationship among AUC, peak, and trough levels between cyclosporine and tacrolimus in renal transplant recipients using new pharmacokinetic parameter--why cyclosporine is monitored by C(2) level and tacrolimus by trough level--.
    Takeuchi H; Matsuno N; Senuma K; Hirano T; Yokoyama T; Taira S; Kihara Y; Kuzuoka K; Konno O; Jojima Y; Mejit A; Akashi I; Nakamura Y; Iwamoto H; Hama K; Iwahori T; Ashizawa T; Nagao T; Toraishi T; Okuyama K; Oka K; Unezaki S
    Biol Pharm Bull; 2008 Jan; 31(1):90-4. PubMed ID: 18175948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.